SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000903423-19-000012
Filing Date
2019-01-10
Accepted
2019-01-10 16:23:40
Documents
1
Period of Report
2019-01-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 5977
  Complete submission text file 0000903423-19-000012.txt   7653
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 55 RAILROAD AVENUE GREENWICH CT 06830
Business Address 55 RAILROAD AVENUE GREENWICH CT 06830 203-863-5000
Viking Global Equities Master Ltd. (Reporting) CIK: 0001759530 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-34949 | Film No.: 19520456